Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Bronchopulmonary Sequestration D001998 3 associated lipids
Ileal Diseases D007077 3 associated lipids
Platelet Storage Pool Deficiency D010981 3 associated lipids
Colitis, Ischemic D017091 3 associated lipids
Extravasation of Diagnostic and Therapeutic Materials D005119 3 associated lipids
Enterocolitis, Necrotizing D020345 3 associated lipids
Dyslexia D004410 3 associated lipids
Milk Hypersensitivity D016269 4 associated lipids
Cluster Headache D003027 4 associated lipids
Cholestasis, Intrahepatic D002780 4 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Leff AR Neurohumoral regulation of airway contractile responses. 1988 Chest pmid:2897271
Junier MP et al. Inhibitory effect of platelet-activating factor (PAF) on luteinizing hormone-releasing hormone and somatostatin release from rat median eminence in vitro correlated with the characterization of specific PAF receptor sites in rat hypothalamus. 1988 Endocrinology pmid:2898362
Guinot P et al. Treatment of adult systemic mastocytosis with a PAF-acether antagonist BN52063. 1988 Lancet pmid:2898694
Michel L et al. Inhibitory effect of oral cetirizine on in vivo antigen-induced histamine and PAF-acether release and eosinophil recruitment in human skin. 1988 J. Allergy Clin. Immunol. pmid:2899102
Michel L et al. Release of PAF-acether and precursors during allergic cutaneous reactions. 1988 Lancet pmid:2899817
Bachelet M et al. Interaction between PAF-acether and drugs that stimulate cyclic AMP in guinea-pig alveolar macrophages. 1988 Eur. J. Pharmacol. pmid:2840303
Anderson GP et al. Increased airways responsiveness to histamine induced by platelet activating factor in the guinea-pig: possible role of lipoxygenase metabolites. 1988 Agents Actions pmid:3136622
Fernandez-Gallardo S et al. Role of paf-acether in the mediation of pathophysiological responses to aggregated immunoglobulins. Studies with the platelet-activating factor receptor antagonist BN 52021. 1988 Int. J. Immunopharmacol. pmid:3139574
Slapke J et al. [Test hierarchy for the development of new drug action principles with the action site in phospholipid metabolism for bronchial asthma and pulmonary hypertension]. 1988 Prax Klin Pneumol pmid:3140230
Ferrell JE et al. Membrane bilayer balance and platelet shape: morphological and biochemical responses to amphipathic compounds. 1988 Biochim. Biophys. Acta pmid:3355815
López-Farré A et al. Glomeruli from ischemic rat kidneys produce increased amounts of platelet activating factor. 1988 Biochem. Biophys. Res. Commun. pmid:3358756
Kuiper J et al. The induction of glycogenolysis in the perfused liver by platelet activating factor is mediated by prostaglandin D2 from Kupffer cells. 1988 Biochem. Biophys. Res. Commun. pmid:3144970
Sun XM and Hsueh W Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor. 1988 J. Clin. Invest. pmid:3366898
Calignano A et al. Isolation and identification of platelet-activating factor in UV-irradiated guinea pig skin. 1988 J Pharmacol Methods pmid:3367652
Nolte D [Bronchial hyperreactivity: pingpong between cells, nerves and mediators]. 1988 Med. Klin. (Munich) pmid:3367876
Bratton DL et al. Effects of platelet activating factor and related lipids on phase transition of dipalmitoylphosphatidylcholine. 1988 Biochim. Biophys. Acta pmid:3370214
Wang J et al. The effects of endotoxin on platelet-activating factor synthesis in cultured rat glomerular mesangial cells. 1988 Biochim. Biophys. Acta pmid:3370222
Dorsch W et al. Anti-asthmatic effects of onions. Alk(en)ylsulfinothioic acid alk(en)yl-esters inhibit histamine release, leukotriene and thromboxane biosynthesis in vitro and counteract PAF and allergen-induced bronchial obstruction in vivo. 1988 Biochem. Pharmacol. pmid:2462422
Cordeiro RS et al. Proinflammatory activity of platelet-activating factor: pharmacological modulation and cellular involvement. 1988 Prog Biochem Pharmacol pmid:3043430
Pirotzky E and Braquet P PAF-acether and kidney pathology. 1988 Prog Biochem Pharmacol pmid:3043431
Feuerstein G and Siren AL Platelet-activating factor and shock. 1988 Prog Biochem Pharmacol pmid:3043432
Godfroid JJ and Heymans F Chemistry of PAF antagonists. 1988 Prog Biochem Pharmacol pmid:3043433
Casals-Stenzel J and Heuer H Pharmacology of PAF antagonists. 1988 Prog Biochem Pharmacol pmid:3043436
Rylander R et al. Modulation of pulmonary inflammation after endotoxin inhalation with a platelet-activating factor antagonist (48740 RP). 1988 Int. Arch. Allergy Appl. Immunol. pmid:3403044
Satoh K et al. [Endothelial injury as an initiating factor: vascular endothelial cell injury and biosynthesis of PAF]. 1988 Nippon Rinsho pmid:3404682
Nogami M et al. [Effects of a PAF antagonist CV-3988 on the acute gastric erosions of rats by water-immersion stress]. 1988 Nihon Shokakibyo Gakkai Zasshi pmid:3404759
Tamura N et al. Leukotriene C4 production from human eosinophils in vitro. Role of eosinophil chemotactic factors on eosinophil activation. 1988 J. Immunol. pmid:2848892
Biologically active ether lipids. 1988 Prog Biochem Pharmacol pmid:3405995
Pretolani M et al. Active immunization induces lung hyperresponsiveness in the guinea pig. Pharmacologic modulation and triggering role of the booster injection. 1988 Am. Rev. Respir. Dis. pmid:3202509
Jancar S et al. Immune complex induced pancreatitis: effect of BN 52021, a selective antagonist of platelet-activating factor. 1988 Prostaglandins pmid:2969600
Tkhostov EB et al. [Calcium metabolism in arterial hypertension. I. Myocardial hypertrophy and hormone-dependent increase in Ca2+ levels in the thrombocytes of patients with arterial hypertension]. 1988 Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR pmid:2969736
Leprevost C et al. Inhibition of eosinophil chemotaxis by a new antiallergic compound (cetirizine). 1988 Int. Arch. Allergy Appl. Immunol. pmid:2971624
Ohmori K et al. Antiinflammatory and antiallergic effects of a novel metabolite of Nocardiopsis sp. as a potent protein kinase C inhibitor from microbial origin. 1988 Arzneimittelforschung pmid:2972291
Masugi F et al. Platelet-activating factor and anti-platelet-aggregating factor in acute reduction of blood pressure following percutaneous transluminal renal angioplasty in patients with renovascular hypertension. 1988 J Hum Hypertens pmid:2977405
Moriyama T et al. Elevation of cytosolic free Ca2+ is directly evoked by thromboxane A2 in human platelets during activation with collagen. 1988 J. Biochem. pmid:3170519
Lagente V et al. PAF-acether and endotoxin display similar effects on rat mesenteric microvessels: inhibition by specific antagonists. 1988 J. Pharmacol. Exp. Ther. pmid:3171975
Danko G et al. Effect of the PAF antagonists, CV-3988 and L-652,731 on the pulmonary and hematological responses to guinea pig anaphylaxis. 1988 Pharmacol Res Commun pmid:3174804
Bussolino F et al. Platelet activating factor induces dopamine release in PC-12 cell line. 1988 Am. J. Physiol. pmid:3177629
Hill CE et al. Location of platelet activating factor binding in rat liver. 1988 Biochem. J. pmid:3178735
Kelefiotis D et al. Study of digoxin as inhibitor of the in vivo effects of acetyl glyceryl ether phosphorylcholine (AGEPC) in mice. 1988 Life Sci. pmid:3339951
Soybel DI et al. Effects of platelet-activating factor on canine gastric mucosal blood flow and permeability to luminal acid. 1988 Am. J. Surg. pmid:3341532
Kumar R et al. Occurrence of platelet-activating factor in rabbit spermatozoa. 1988 Arch. Biochem. Biophys. pmid:3341753
Huo YN et al. A preferential inhibition by Zn2+ on platelet activating factor- and thrombin-induced serotonin secretion from washed rabbit platelets. 1988 Arch. Biochem. Biophys. pmid:3341767
Worthen GS et al. The priming of neutrophils by lipopolysaccharide for production of intracellular platelet-activating factor. Potential role in mediation of enhanced superoxide secretion. 1988 J. Immunol. pmid:2834441
Touvay C et al. Role of platelet-activating factor (PAF) in the bronchopulmonary alterations and beta-adrenoceptor function induced by endotoxin. 1988 Biochem. Biophys. Res. Commun. pmid:2835036
17th annual UCLA symposium. Abstracts: Cell activation and signal initiation: receptor and phospholipase control of inositol phosphate, PAF and eicosanoid production. 1988 J. Cell. Biochem. Suppl. pmid:2835556
Mest HJ et al. The arrhythmogenic effect of platelet activating factor (PAF) is inhibited by PAF antagonist and by substances influencing eicosanoids. 1988 Biomed. Biochim. Acta pmid:3248107
Wainwright CL et al. The effects of PAF antagonists on ischaemia and reperfusion arrhythmias and ischaemia-induced platelet aggregation. 1988 Biomed. Biochim. Acta pmid:3248108
Dembińska-Kieć A et al. Release of cysteinyl-leukotrienes is of minor importance in PAF induced reduction of perfusion rate in the gastric vascular bed. 1988 Biomed. Biochim. Acta pmid:3248109
Ostermann G et al. Structure-activity relationships of synthetic analogues of platelet-activating factor. 1988 Biomed. Biochim. Acta pmid:3248110
Droy-Lefaix MT et al. The amplificative role of PAF-acether in the oxidative stress following reperfusion of ischemic stomach. 1988 Basic Life Sci. pmid:3250539
Leslie CC et al. Properties and purification of an arachidonoyl-hydrolyzing phospholipase A2 from a macrophage cell line, RAW 264.7. 1988 Biochim. Biophys. Acta pmid:3143418
Egger M et al. Human platelet electrorotation change induced by activation: inducer specificity and correlation to serotonin release. 1988 Biochim. Biophys. Acta pmid:3143424
Pitcock JA Morphometric studies of the renomedullary interstitial cells. 1988 Am. J. Med. Sci. pmid:3284348
Tahraoui L et al. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation. 1988 Mol. Pharmacol. pmid:2842653
Garcia JG et al. Effect of platelet activating factor on leukocyte-endothelial cell interactions. 1988 Thromb. Res. pmid:2842887
Ng DS and Wong K Specific binding of platelet-activating factor (PAF) by human peripheral blood mononuclear leukocytes. 1988 Biochem. Biophys. Res. Commun. pmid:2843182
Browne PC et al. Kinetics of the formation of thrombin-thrombospondin complexes: involvement of a 77-kDa intermediate. 1988 Arch. Biochem. Biophys. pmid:2844122
Wykle RL et al. Platelet-activating factor. 1988 Meth. Enzymol. pmid:3237085
Kioumis I et al. Effect of inhaled platelet-activating factor on circulating neutrophils and platelets in vivo and ex vivo in man. 1988 Prostaglandins pmid:3237997
Sirois MG et al. PAF increases vascular permeability in selected tissues: effect of BN-52021 and L-655,240. 1988 Prostaglandins pmid:3238010
Schindler PW et al. Fluorophore-labeled ether lipids: substrates for enzymes of the platelet-activating factor cycle in peritoneal polymorphonuclear leukocytes. 1988 Anal. Biochem. pmid:3239750
Silva PM et al. Adrenalectomy exacerbates paw edema without interfering with desensitization induced by PAF-acether in rats. 1988 Braz. J. Med. Biol. Res. pmid:3240383
Ghigo D et al. Role of Na+/H+ exchange in thrombin-induced platelet-activating factor production by human endothelial cells. 1988 J. Biol. Chem. pmid:2848827
Aratani H et al. Effect of etizolam (Depas) on production of superoxide anion by platelet-activating factor and N-formyl-methionyl-leucyl-phenylalanine-stimulated guinea pig polymorphonuclear leukocytes. 1988 Jpn. J. Pharmacol. pmid:2848961
Robertson DN et al. The effect of platelet-activating factor on histamine and muscarinic receptor function in guinea pig airways. 1988 Am. Rev. Respir. Dis. pmid:2849329
Martin J Platelet-activating factor. 1988 Dec 24-31 Lancet pmid:2904593
Gebhardt BM et al. Modulation of in vitro immune reactions by platelet activating factor and a platelet activating factor antagonist. 1988 Jan-Feb Immunopharmacology pmid:2966135
Santos OF et al. [Platelet activating factor in nephrology: physiopathologic and therapeutic perspectives]. 1988 Jul-Aug Rev Paul Med pmid:3076976
Lakin KM et al. [Effect of analogs and antagonists of the thrombocyte-activating factor (PAF) on blood platelet aggregation]. 1988 Jul-Aug Farmakol Toksikol pmid:2847936
Whatley RE et al. Endothelium from diverse vascular sources synthesizes platelet-activating factor. 1988 May-Jun Arteriosclerosis pmid:3130833
Di Marzo V et al. Neuropeptides and leukotriene biosynthesis: the effect of calcitonin, peptide histidine valine-42, helodermin, neuropeptide Y and galanin. 1988 May-Jun Neuropeptides pmid:2458537
Bellioni P et al. [Histomorphological changes in nasal polyps in patients with glucose metabolism disorders]. 1988 Nov-Dec Acta Otorhinolaryngol Ital pmid:3247845
Labrakis-Lazanas K et al. PAF of biological fluids in disease: blood levels in allergic rhinitis. 1988 Sep-Oct Haematologica pmid:3143636
Lapointe DS and Olson MS Alteration of hepatic tissue spaces by platelet-activating factor and phenylephrine. 1989 Hepatology pmid:2643546
Schleiffenbaum B et al. The cell surface glycoprotein Mac-1 (CD11b/CD18) mediates neutrophil adhesion and modulates degranulation independently of its quantitative cell surface expression. 1989 J. Immunol. pmid:2565926
Yeo YK et al. The effect of long-term consumption of fish oil on platelet-activating factor synthesis in rat renal microsomes. 1989 Biochem. Biophys. Res. Commun. pmid:2543394
Nakashima S et al. Mechanism of arachidonic acid liberation in platelet-activating factor-stimulated human polymorphonuclear neutrophils. 1989 J. Immunol. pmid:2545786
Gudgeon JR and Martin W Modulation of arterial endothelial permeability: studies on an in vitro model. 1989 Br. J. Pharmacol. pmid:2514947
Bahrami S et al. Effect of PAF-antagonists in endotoxin shock--ovine and rat experiments. 1989 Prog. Clin. Biol. Res. pmid:2780740
Pignol B et al. Effect of long-term treatment with platelet-activating factor on cytokine production by rat spleen cells. 1989 Int. Arch. Allergy Appl. Immunol. pmid:2785086
Adolfs MJ et al. PAF-acether modifies human peritoneal macrophage cAMP levels in a biphasic fashion. 1989 Agents Actions pmid:2540635
Neumann M and Kownatzki E The effect of adherence on the generation of reactive oxygen species by human neutrophilic granulocytes. 1989 Agents Actions pmid:2540640
Foegh ML et al. Platelet-activating factor in organ transplant rejection. 1989 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2526501
Pickett WC and Ramesha C Modulation of mediator precursors by changes in essential fatty acid composition. 1989 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2526546
Stoll LL and Spector AA Interaction of platelet-activating factor with endothelial and vascular smooth muscle cells in coculture. 1989 J. Cell. Physiol. pmid:2715186
Sloan IG and Firkin BG Impaired fibrinolysis in patients with thrombotic or haemostatic defects. 1989 Thromb. Res. pmid:2814943
Mita H et al. Quantitation of platelet-activating factor by high-performance liquid chromatography with fluorescent detection. 1989 Anal. Biochem. pmid:2817335
Hopp RJ et al. Effect of platelet-activating factor inhalation on nonspecific bronchial reactivity in man. 1989 Chest pmid:2680318
Mandi Y et al. The effect of the platelet-activating factor antagonist, BN 52021, on human natural killer cell-mediated cytotoxicity. 1989 Immunology pmid:2759659
O'Neill C et al. Embryo-derived platelet-activating factor. 1989 J. Reprod. Fertil. Suppl. pmid:2681737
Lister MD et al. Inhibition studies on the membrane-associated phospholipase A2 in vitro and prostaglandin E2 production in vivo of the macrophage-like P388D1 cell. Effects of manoalide, 7,7-dimethyl-5,8-eicosadienoic acid, and p-bromophenacyl bromide. 1989 J. Biol. Chem. pmid:2498315
Peterson JR et al. Platelet activating factor antagonist design: structure of methyl trans-5-(3,4-dimethoxyphenyl)-2,3,4,5-tetrahydro-2-oxo-4- furancarboxylate. 1989 Acta Crystallogr C pmid:2610971
Peterson JR et al. Platelet activating factor antagonist design. 2. X-ray structure of dimethyl 2,3,4,5-tetrahydro-5 beta-(3,4-methylenedioxyphenyl)-2-oxo-3 beta-(3,4,5-trimethoxybenzoyl)-3 alpha,4 alpha-furandicarboxylate. 1989 Acta Crystallogr C pmid:2610989
Yanagihara Y et al. Immunopharmacological studies on TBX, a new antiallergic drug (3). Inhibitory effects on histamine release from lung fragments and bronchoconstriction in guinea pigs. 1989 Jpn. J. Pharmacol. pmid:2478743
Tosaki A et al. Possible involvement of platelet activating factor in anaphylaxis of passively sensitised, isolated guinea pig hearts. 1989 Cardiovasc. Res. pmid:2557156
Levi R et al. Alkyl chain homologs of platelet-activating factor and their effects on the mammalian heart. 1989 Biochem. Biophys. Res. Commun. pmid:2742592
Turner MR and Lumb RH Synthesis of platelet activating factor by tissues from the rainbow trout, Salmo gairdneri. 1989 Biochim. Biophys. Acta pmid:2742873
Bylin G [Platelet activating factor--a new agent to control asthma]. 1989 Lakartidningen pmid:2921909
Jin LS et al. Inhibition of bradykinin-induced bronchoconstriction in the guinea-pig by a synthetic B2 receptor antagonist. 1989 Br. J. Pharmacol. pmid:2547478